|
|
|
Volumn , Issue 2, 2011, Pages 106-110
|
|
[Modern approach to the prevention and treatment of NSAID-gastropathy].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIULCER AGENT;
DICLOFENAC;
FAMOTIDINE;
GASTRIN;
GASTRIN 17;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN;
ARTICLE;
BIOSYNTHESIS;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
HUMAN;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
PEPTIC ULCER;
PHASE 4 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
STOMACH MUCOSA;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTI-ULCER AGENTS;
DICLOFENAC;
FAMOTIDINE;
GASTRIC MUCOSA;
GASTRINS;
HUMANS;
MIDDLE AGED;
PEPTIC ULCER;
PROSTAGLANDINS;
TREATMENT OUTCOME;
|
|
EID: 79960169842
PISSN: 16828658
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
